https://doi.org/10.4081/monaldi.2021.1377
Clinical and epidemiological profile of Indian COVID-19 patients from Jaipur: a descriptive study
Submitted: May 13, 2020
Accepted: December 14, 2020
Published: July 21, 2021
Accepted: December 14, 2020
Abstract Views: 1560
PDF: 782
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
We analyzed the data of 102 confirmed patients with novel Coronavirus 2 infection (COVID-19) during the early period of nationwide lockdown announced in India after the declaration of pandemic. We analyzed epidemiological, clinical characteristics and outcome of hospitalization in 102 patients with positive results for novel corona virus (SARS-CoV-2) RNA testing which were traced on the basis of history of travel, contact with a confirmed COVID-19 case, resident of hotspot areas or presence of symptoms, thus providing an accurate estimate of the proportion of asymptomatic cases in the initial population. Of 102 patients enrolled in the study, 83.3% (85/102) were asymptomatic and 16.67% (17/102) were symptomatic. Seventy-seven (75.49%) were males and 24.50% (25/102) were females. Eighteen (17.6%) patients had associated comorbidities, the most prevalent of which were diabetes mellitus 10.8% (11/102), hypertension 7.8% (8/102), chronic obstructive pulmonary disease (COPD) in 3.92% (4/102), chronic kidney Disease (CKD) 0.98% (1/102), coronary artery Disease (CAD) 0.98% (1/102) and cerebro-vascular disease (CVD) 0.98% (1/102). The clinical spectrum among symptomatic COVID-19 patients varied from dry cough and fever to respiratory failure and multi-organ failure. Twelve (11.76%) patients were kept in intensive care unit (ICU). Ninety-nine (97.05%) patients recovered while three (2.94%) died during hospital stay. With majority of COVID-19 cases in India being asymptomatic, changes in biochemical and inflammatory profile were small and insignificant in asymptomatic patients when compared to symptomatic patients. Elevated NLR, lymphopenia, age and presence of comorbidities were associated with increased severity and poor outcome.
WHO. Pneumonia of unknown cause China. Emergencies, preparedness, response, disease outbreak news. World Health
Organization. 2020. Accessed: 8 May 2020. Available from: https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/
Centers for Disease Control and Prevention. 2019 Novel Coronavirus, Wuhan, China. CDC. Accessed: 27 January 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/about/%20index.html
WHO. Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. World Health Organization. 2020. Accessed: 4 May 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-themedia-briefing-on-2019-ncov-on-11-february-2020
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536-44.
DOI: https://doi.org/10.1038/s41564-020-0695-z
WHO. Coronavirus pandemic. World Health Organization. 2020. Accessed: 25 July 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Government of India [Internet]. #IndiaFightsCorona COVID-19. 2020. Accessed: 25 July 2020. Available from: https://www.mygov.in/COVID-19
Huang L, Zhang X, Zhang X, et al. Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: A prospective contact-tracing study. J Infect 2020;80:e1-13.
DOI: https://doi.org/10.1016/j.jinf.2020.03.006
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-13.
DOI: https://doi.org/10.1016/S0140-6736(20)30211-7
Huang C,Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.
DOI: https://doi.org/10.1016/S0140-6736(20)30183-5
Kolifarhood G, Aghaali M, Mozafar Saadati H, et al. Epidemiological and clinical aspects of covid-19; a narrative review. Arch Acad Emerg Med 2020;8:e41.
Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020;71:732-9.
DOI: https://doi.org/10.1093/cid/ciaa237
Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person
transmission: a study of a family cluster. Lancet 2020;395:514-23.
DOI: https://doi.org/10.1016/S0140-6736(20)30154-9
Ministry of Health and Family Welfare, Government of India. Guidelines on the clinical management of COVID-19. Accessed: 8 May 2020. Available from: https://www.mohfw.gov.in/pdf/GuidelinesonClinicalManagementofCOVID1912020.pdf
Şimşek yavuz S, Ünal S. Antiviral treatment of COVID-19. Turk J Med Sci 2020;50:611-9.
DOI: https://doi.org/10.3906/sag-2004-145
Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-
cases on board the Diamond Princess Cruise ship, Yokohama, Japan, 2020. Euro Surveill 2020;25:2000180.
DOI: https://doi.org/10.2807/1560-7917.ES.2020.25.10.2000180
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA 2020;323:1239-42.
DOI: https://doi.org/10.1001/jama.2020.2648
Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-5.
DOI: https://doi.org/10.1016/j.ijid.2020.03.017
Shi H, Han X, Jiang N et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020;20:425-34.
DOI: https://doi.org/10.1016/S1473-3099(20)30086-4
Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol 2020;146:110-8.
DOI: https://doi.org/10.1016/j.jaci.2020.04.006
Gautret P, Lagier JC, Parola P, et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin
in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis 2020;34:101663.
DOI: https://doi.org/10.1016/j.tmaid.2020.101663
Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19. N Engl J Med 2020;382:1787-99.
DOI: https://doi.org/10.1056/NEJMc2008043
Baden LR, Rubin EJ. Covid-19 - The search for effective therapy. N Engl J Med 2020;382:1851-2.
DOI: https://doi.org/10.1056/NEJMe2005477
European Centre for Disease Prevention and Control. Guidance for discharge and ending isolation in the context of widespread
community transmission of COVID-19, 8 April 2020. Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/en/publications-data/covid-19-guidance-discharge-and-endingisolation
How to Cite
Mahavar, Sunil, Princy Tyagi, Abhishek Agrawal, Sudhir Bhandari, Subrata Banerjee, Raman Sharma, and Prakash Keshwani. 2021. “Clinical and Epidemiological Profile of Indian COVID-19 Patients from Jaipur: A Descriptive Study”. Monaldi Archives for Chest Disease 91 (2). https://doi.org/10.4081/monaldi.2021.1377.
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- F. Blasi, S. Aliberti, Pneumonia: how important are local epidemiology and smoking habits? , Monaldi Archives for Chest Disease: Vol. 65 No. 1 (2006): Pulmonary series
- Giovanni Pulignano, Maria Denitza Tinti, Donatella Del Sindaco, Stefano Tolone, Giovanni Minardi, Antonio Lax, Massimo Uguccioni, Barriers to cardiac rehabilitation access of older heart failure patients and strategies for better implementation , Monaldi Archives for Chest Disease: Vol. 84 No. 1-2 (2015): Cardiac series
- Alessandra Schiavo, Francesca M. Stagnaro, Andrea Salzano, Alberto M. Marra, Emanuele Bobbio, Pietro Valente, Simona Grassi, Martina Miniero, Michele Arcopinto, Margherita Matarazzo, Raffaele Napoli, Antonio Cittadini, Pregabalin-induced first degree atrioventricular block in a young patient treated for pain from extrapulmonary tuberculosis , Monaldi Archives for Chest Disease: Vol. 87 No. 3 (2017)
- Daniel Brito, Igor Goykhman, Kevin Bryan Lo, Yaser Alhamshari, Jorge Luis Peñalver, Francisco Aguilar, Eduardo Quintero, Aditi Kalla, Evan Friend, Gregg S. Pressman, Aortic stenosis calcium scoring in a racially mixed sample , Monaldi Archives for Chest Disease: Vol. 90 No. 4 (2020)
- Enrico Vassallo, Francesca Musella, Susanna Mosca, Laura Casaretti, Roberto Formisano, Giacomo Mattiello, Ada Bologna, Irma Fabiani, Francesco Gambardella, Laura Petraglia, Giuseppe Rengo, Dario Leosco, Pasquale Perrone-Filardi, Clinical and therapeutic value of carotid intima-media thickness , Monaldi Archives for Chest Disease: Vol. 76 No. 3 (2011): Cardiac series
- Agata Buonacera, Benedetta Stancanelli, Lorenzo Malatino, Management of hypertension in the elderly: Looking for a trade-off between cardiovascular prevention and serious adverse events , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Giampaolo Scorcu, Annarita Pilleri, Paolo Contu, Pompilio Faggiano, Roberto Floris, Alessandra Mereu, Luisella Pistis, Roberto Sessego, Luigi Valentino, Claudia Sardu, Preoperative assessment of cardiovascular risk in patients undergoing noncardiac surgery: the Orion study , Monaldi Archives for Chest Disease: Vol. 90 No. 1 (2020)
- Vivek Sharma, Pruthu Thekkur, Poonam R. Naik, Brojo Kishore Saha, Niraj Agrawal, Milan K. Dinda, S. Parthiban, Abhijit Dey, Basavaraj Poojar, Amrita N. Shamanewadi, Srinath Satyanarayana, Treatment success rates among tuberculosis patients notified from the private sector in West Bengal, India , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Francesca Musella, Roberto Formisano, Giacomo Mattiello, Elisabetta Iardino, Laura Petraglia, Alice Vitagliano, Irma Fabiani, Anna Paola Cirillo, Marta Petito, Pasquale Perrone-Filardi, Coronary computed tomography: current role and future perspectives for cardiovascular risk stratification , Monaldi Archives for Chest Disease: Vol. 76 No. 3 (2011): Cardiac series
- M. Lusuardi, G. Garuti, M. Massobrio, L. Spagnolatti, S. Bendinelli, Heart and Lungs in COPD. Close friends in real life - separate in daily medical practice? , Monaldi Archives for Chest Disease: Vol. 69 No. 1 (2008): Pulmonary series
<< < 58 59 60 61 62 63 64 65 66 67 > >>
You may also start an advanced similarity search for this article.
